Cargando…
The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury
Neuropathic pain is a pathological pain state with a broad symptom scope that affects patients after nerve injuries, but it can also arise after infections or exposure to toxic substances. Current treatment possibilities are still limited because of the low efficacy and severe adverse effects of ava...
Autores principales: | Wedel, Saskia, Hahnefeld, Lisa, Alnouri, Mohamad Wessam, Offermanns, Stefan, Hausch, Felix, Geisslinger, Gerd, Sisignano, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695264/ https://www.ncbi.nlm.nih.gov/pubmed/36430751 http://dx.doi.org/10.3390/ijms232214274 |
Ejemplares similares
-
SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators
por: Wedel, Saskia, et al.
Publicado: (2023) -
SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain
por: Wedel, Saskia, et al.
Publicado: (2022) -
Sex differences in the effect of the FKBP5 inhibitor SAFit2 on anxiety and stress-induced reinstatement following cocaine self-administration
por: Connelly, Krista L., et al.
Publicado: (2020) -
The Many Faces of FKBP51
por: Hähle, Andreas, et al.
Publicado: (2019) -
FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
por: Hähle, Andreas, et al.
Publicado: (2019)